Search & Analyze

Strides Pharma Science Ltd.

1,057.85−39.55 (−3.60%)

BSE · 30 Oct, 4:01 PM

: ₹9,855.45 Cr
: 15.98
: 1,21,164
: ₹1,077.20 - ₹973.75
: ₹1,260.10 - ₹769.60

Strides Pharma Science Ltd. (STAR) share price closed at ₹1,057.85 on the BSE on Friday, October 30, 2026, down by 3.60% from its of ₹1,097.40. In that session STAR reached a of 1,077.20 and of 973.75. The for the session was 1,023.00. The stands at 1,093.99 and is at 1,019.02. Looking at , the stock ended the session moving sideways.

Stock Overview

₹1,056.70

₹1,097.40

₹1,023.00

₹1,093.99

Price 3.30% below

₹1,019.02

Price 3.81% above

Key Fundamentals

: 9,855.45 Cr₹9.86 Thousand Crore
: 66.91
: 15.98
: 3.01
: 355.18
: 1,080.30 Cr₹1.08 Thousand Crore
: 0.47 %
Sector
Industry: Pharmaceuticals & Drugs
: 20.31
: 0.54

Industry Comparison

Ratio	Company	Sector
	15.98	44.77
	0.54	0.20
	3.01	4.61
	1.25	1.81
	0.47 %	0.11 %
Operating Margin	11.95 %	19.15 %

Sector figures are the median of 154 listed Healthcare companies.

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,778.25	38.91	4,26,661.74	0.90	1,995.07	-36.16%	16,198.71	11.88%	19.11
DIVI'S LAB. DIVISLAB	9,715.00	88.17	2,57,902.73	0.31	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,635.15	83.01	1,76,306.21	0.82	534.00	-9.64%	4,979.00	50.79%	19.27
LAURUSLABS LAURUSLABS	2,392.00	96.46	1,29,242.68	0.08	436.19	124.27%	2,206.37	33.44%	18.20
ZYDUSLIFE ZYDUSLIFE	1,244.00	27.50	1,24,089.48	0.08	990.20	-34.90%	8,017.00	21.96%	21.39
DR.REDDY'S DRREDDY	1,350.20	40.25	1,12,698.53	0.59	913.20	-31.69%	8,697.80	-1.48%	13.75
CIPLA LTD. CIPLA	1,380.00	38.48	1,11,488.55	0.94	851.51	-37.08%	7,403.93	-2.44%	16.00
Strides Pharma Science Ltd. STAR	1,057.85	15.98	9,855.45	0.47	134.12	1.97%	1,429.73	17.11%	18.57

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
	1,043.50	1,054.34	1,166.93	1,153.67	1,190.39	1,119.74	1,220.83	1,194.65	1,323.47	1,265.41	1,429.73
Expenses	839.19	864.31	982.33	943.36	972.53	901.66	989.26	958.70	1,083.76	1,035.63	1,178.82
	204.31	190.03	184.60	210.31	217.87	218.07	231.57	235.94	239.71	229.77	250.91
	19.58%	18.02%	15.82%	18.23%	18.30%	19.48%	18.97%	19.75%	18.11%	18.16%	17.55%
	-21.62	111.09	24.54	3.19	-15.44	0.22	35.91	103.56	1.72	68.09	5.79
Interest	71.10	72.52	73.82	52.18	50.32	47.46	46.13	43.38	41.58	40.56	46.54
	47.94	46.52	48.45	48.42	48.86	48.89	49.64	50.62	53.25	56.40	57.21
	28.68	180.49	86.21	113.85	106.38	122.04	153.12	245.48	148.05	199.62	150.44
	43.66%	10.54%	16.17%	20.91%	19.51%	13.48%	14.10%	15.22%	12.68%	17.09%	10.85%
	18.18	3,351.47	71.84	87.95	82.19	99.61	127.53	202.11	126.94	156.91	130.84
	1.98	364.62	7.81	9.54	8.92	10.81	13.84	21.93	13.77	17.03	14.19

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	5,327.24	6,245.43	6,089.31	7,091.20	7,068.31
	3,070.25	3,688.39	3,890.13	4,565.34	4,858.68
EXPENDITURE :
Increase/Decrease in Stock	95.28	-2.67	43.07	-184.01	38.28
Raw Material Consumed	1,407.04	1,629.55	1,705.99	2,163.97	1,920.46
Power & Fuel Cost	71.54	85.82	75.13	58.17	66.38
Employee Cost	646.91	732.02	737.05	862.76	928.96
Other Manufacturing Expenses	255.52	259.45	299.81	311.98	402.64
General and Administration Expenses	223.67	232.21	198.06	221.56	251.45
Selling and Distribution Expenses	331.30	263.65	215.03	298.20	357.11
Miscellaneous Expenses	60.50	103.06	43.76	34.93	48.85
	3,091.76	3,303.09	3,317.89	3,767.56	4,014.13
Operating Profit (Excl OI)	-21.51	385.29	572.24	797.77	844.56
	133.40	135.22	49.85	63.76	231.45
	111.88	520.51	622.09	861.53	1,076.01
Interest	176.74	261.14	280.22	248.85	178.55
PBDT	-64.86	259.37	341.86	612.68	897.46
	233.01	243.25	213.64	192.26	202.40
Profit Before Taxation & Exceptional Items	-297.88	16.12	128.22	420.42	695.06
Exceptional Income / Expenses	-243.83	-17.03	-189.05	64.66	-26.84
	-652.51	-286.20	-114.79	486.92	668.69
Provision for Tax	-178.26	-55.30	29.11	77.52	94.17
	-474.25	-230.90	-143.90	409.41	574.52
Extra items			49.59	3,188.11	0.00
Minority Interest	14.04	9.70	23.70	-4.06	-18.33
Consolidated Net Profit	-460.21	-202.64	-70.61	3,593.46	556.19
Profit Balance B/F	484.95	2.31	-200.33	-284.49	458.92
Appropriations	24.74	-200.33	-270.94	3,308.96	1,015.11
Equity Dividend %		15.00%	25.00%	40.00%	50.00%
	-51.25	-22.44	-7.68	389.90	60.34
Adjusted EPS	-51.25	-22.44	-7.68	389.90	60.34

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	89.79	90.30	91.90	92.16	92.17
Share Warrants & Outstandings	2.45	19.42	3.09	0.51	0.56
Total Reserves	2,266.99	2,102.54	2,030.57	2,459.16	3,014.84
Reserve excluding Revaluation Reserve	2,266.99	2,102.54	2,030.57	2,459.16	3,014.84
	2,359.23	2,212.26	2,125.57	2,551.83	3,107.57
Minority Interest	24.09	-39.38	-53.86	34.63	41.77
Secured Loans	744.86	1,040.81	618.40	558.62	536.45
Unsecured Loans	90.77	98.98	53.10	12.62	15.87
Deferred Tax Assets / Liabilities	-179.43	-220.46	-227.00	-149.78	-163.19
Other Long Term Liabilities	245.25	217.55	85.32	66.21	83.05
Long Term Provisions	64.28	73.42	91.63	113.94	126.36
Total Non-Current Liabilities	965.72	1,210.30	621.44	601.61	598.54
Trade Payables	1,071.52	982.34	851.59	1,032.50	1,309.68
Other Current Liabilities	697.18	527.89	341.57	307.41	401.72
Short Term Borrowings	1,496.53	1,330.76	1,574.15	1,136.36	1,039.34
Short Term Provisions	146.43	149.20	111.94	115.25	144.75
Total Current Liabilities	3,411.68	2,990.20	2,879.26	2,591.52	2,895.49
Total Liabilities	6,760.71	6,373.39	5,572.41	5,779.59	6,643.37
Gross Block	3,231.69	3,324.82	2,873.18	2,897.25	3,303.39
Less: Accumulated Depreciation	898.24	1,026.40	1,020.00	1,009.14	1,203.04
	2,333.46	2,298.42	1,853.18	1,888.12	2,100.35
	56.23	48.26	79.88	99.65	161.12
Non Current Investments	540.34	438.96	196.93	339.71	291.36
Long Term Investment	540.34	438.96	196.93	339.71	291.36
Long Term Loans & Advances	210.58	217.18	256.13	140.19	163.66
Other Non Current Assets	10.26	11.91	123.38	94.73	27.14
Total Non-Current Assets	3,398.88	3,130.03	2,603.41	2,680.68	3,030.03
Currents Investments		50.84	105.76	69.50
Inventories	1,173.80	1,146.50	1,126.24	1,277.57	1,634.79
Sundry Debtors	1,207.30	1,299.40	1,141.87	1,202.94	1,288.96
Cash and Bank	187.35	315.96	191.17	136.78	213.14
Other Current Assets	647.90	169.21	228.99	276.20	321.04
Short Term Loans and Advances	145.49	153.34	174.97	135.92	154.85
Total Current Assets	3,361.83	3,135.25	2,969.00	3,098.91	3,612.79
Net Current Assets (Including Current Investments)	-49.84	145.05	89.74	507.39	717.30
Total Assets	6,760.71	6,373.39	5,572.41	5,779.59	6,643.37
	834.42	632.08	474.83	98.09	118.51
Total Debt	2,791.96	2,774.46	2,414.53	1,795.61	1,668.69
	262.48	242.83	230.95	276.83	337.08
Adjusted Book Value	262.48	242.83	230.95	276.83	337.08

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	-652.51	-267.63	-62.72	3,675.03	668.69
Adjustment	582.27	682.19	818.27	-2,884.12	205.39
Changes In working Capital	-189.90	-457.80	-78.73	-173.58	-100.45
Cash Flow after changes in Working Capital	-260.14	-43.23	676.82	617.34	773.63
Cash Flow from Operating Activities	-257.82	44.41	701.07	684.37	702.52
Cash Flow from Investing Activities	-118.73	302.47	-150.25	-89.69	-173.04
Cash Flow from Financing Activitie	421.32	-213.92	-693.32	-642.58	-453.41
Net Cash Inflow / Outflow	44.77	132.96	-142.51	-47.90	76.07
Opening Cash & Cash Equivalents	125.83	170.73	303.50	161.02	112.56
Cash & Cash Equivalent of Subsidiaries under liquidations		-0.34	-0.14	-0.02
Effect of Foreign Exchange Fluctuations	0.13	0.15	0.16	-0.54	0.06
Closing Cash & Cash Equivalent	170.73	303.50	161.02	112.56	188.70

Ratios

Valuation

15.98

3.01

10.70

1.89

66.91

355.18

Profitability

20.31

18.57

9.25

11.95

8.13

Leverage & Liquidity

0.54

1.25

4.75

Returns

0.47

1.14

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26	Sep '26
	25.86	25.84	26.82	28.30	28.30	27.86	27.86	27.91	27.91	29.00
	45.28	48.33	45.41	42.05	41.33	41.50	42.55	43.14	43.81	43.50
	28.87	25.83	27.77	29.65	30.37	30.64	29.59	28.95	28.28	27.51
	74.14	74.16	73.18	71.70	71.70	72.14	72.14	72.09	72.09	71.00
No. of Shareholders	91,917	96,009	1,14,236	95,125	92,889	91,206	85,589	86,616	94,850	93,336

Mutual Funds Invested(15)

Based on each fund's latest monthly portfolio · Sep 2026

A total of 6 active funds hold 10.17% in Strides Pharma Science Ltd., contributing to ₹1.05K Cr of holdings

Fund				As of
QU Quant Small Cap Fund - Growth - Direct PlanSmall cap Fund	440.06	1.24	39,29,137	Sep '26
ID Bandhan Small Cap Fund - Growth - Direct PlanSmall cap Fund	293.54	0.82	26,20,885	Sep '26
QU Quant Multi Cap Fund - Growth - Direct PlanMulti Cap Fund	159.26	2.12	14,22,000	Sep '26
AX Axis Small Cap Fund - Growth - Direct PlanSmall cap Fund	82.32	0.27	7,35,028	Sep '26
QU Quant Healthcare Fund - Growth - Direct PlanPharma & Health Care	38.36	9.04	3,42,537	Sep '26
AB Aditya Birla Sun Life Value Fund - Growth - Direct PlanEquity - Value Fund	36.62	0.55	3,26,991	Sep '26
MO Motilal Oswal Nifty Microcap 250 Index Fund - Growth - Direct PlanIndex Funds - Other	20.11	0.83	1,79,543	Sep '26
MO Motilal Oswal BSE Healthcare ETFIndex	0.21	0.47	1,849	Sep '26
IN Groww Nifty Total Market Index Fund - Growth - Direct PlanIndex Funds - Other	0.13	0.04	1,173	Sep '26
ID Bandhan BSE Healthcare Index Fund - Growth - Direct PlanIndex Funds - Other	0.10	0.47	872	Sep '26

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-10-23	Board Meeting	Quarterly Results
2026-07-24	Board Meeting	Quarterly Results
2026-05-18	Ex Dividend	Rs.5.0000 per share(50%)Final Dividend	2026-07-31	2026-07-31

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Strides Pharma Science Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

11 members across the board and senior leadership

Manjula Ramamurthy

Company Secretary & Compliance Officer

—

Arun Kumar

Chairman

₹3.64 Cr

Mar '26

Kausalya Santhanam